Transformation of Indigenous Primary Healthcare Delivery

Overview

Context: Indigenous peoples experience higher prevalence rates of diabetes and worse health outcomes compared to the general population because of a wide array of factors: social determinants of health, lifestyle, genetic susceptibility, and historic-political and psycho-social factors. Barriers to care that are unique to First Nations communities exacerbate the problem with fragmented healthcare, poor chronic disease management, healthcare staff turnover, and limited, or non-existent, surveillance. Program: The TransFORmation of IndiGEnous PrimAry HEAlthcare Delivery (FORGE AHEAD) research program aims to develop and evaluate community-driven, culturally relevant, primary healthcare models that enhance chronic disease prevention and management in First Nations communities in Canada. Participants will consist of Indigenous community and clinic team members that will take part in multiple interrelated projects including community profiling, readiness consultations, diabetes registry and surveillance, and quality improvement workshops and action periods. Design: This mixed-method pre-post observational study will capture: 1) diabetes clinical process and outcomes measures, 2) details about community-driven innovations, and 3) knowledge about the experience and cost of attempting to improve primary delivery in individual Indigenous communities. Intervention/Instrument: Survey, literature review, 15 month intervention (readiness consultations, implementation and maintenance of a registry and surveillance system, community and clinic focused quality improvement workshops), interviews. Measures: Primary- mean A1C of patients with diabetes (A1C ≥ 8.0% at baseline); Secondary-clinical process and outcome measures, change in stage of readiness, description of participation and innovation facilitators and barriers. Policy Implications: The outcomes of this research program have the potential to significantly affect future policy decisions pertaining to chronic disease care in First Nations communities. Policy recommendations will be made to help support Indigenous communities in adopting successful innovations to help address issues related to diabetes and other chronic illnesses. The community-driven innovations developed in FORGE AHEAD and the subsequent policy decisions may enhance chronic disease prevention and management for Indigenous peoples across the country.

Full Title of Study: “Transformation of Indigenous Primary Healthcare Delivery (FORGE AHEAD): Community-driven Innovations and Strategic Scale-up Toolkits”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 2017

Interventions

  • Behavioral: Quality Improvement
    • Community and Clinical Teams engaged in implementing Quality Improvement initiatives to improve diabetes prevention and management within their First Nations community and clinic.

Arms, Groups and Cohorts

  • 11 First Nations Community and Clinical Teams
    • 11 Community & Clinical Teams in each First Nation community participated in the intervention.

Clinical Trial Outcome Measures

Primary Measures

  • mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
    • Time Frame: repeated measures: baseline (12 months prior to the start of the program)
  • mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
    • Time Frame: repeated measures: 6 month after program start date
  • mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
    • Time Frame: repeated measures: 12 month after program start date
  • mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
    • Time Frame: repeated measure: 18 months after program start
  • mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
    • Time Frame: repeated measure: 24 months after program start

Participating in This Clinical Trial

Community members Inclusion Criteria:

  • 18 years of age or older – on-reserve residents of participating Indigenous community partners Exclusion Criteria:

  • less than 18 years of age – off-reserve residents of participating or non-participating Indigenous community partners Clinic team members Inclusion Criteria:

  • Health centers of participating Indigenous community partners – Current type 2 diabetes mellitus registry and surveillance system Exclusion Criteria:

  • Health centers of non-participating Indigenous community partners – No registry or surveillance system Diabetes Registry Inclusion Criteria:

  • adults (age≥ 18 years) with type 2 diabetes and most recent HbA1C≥ 8.0% Exclusion Criteria:

  • gestational diabetes, type 1 diabetes, or severe co-morbidity associated with life expectancy <6 months.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Lawson Health Research Institute
  • Collaborator
    • Canadian Institutes of Health Research (CIHR)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Stewart B Harris, MD, MPH, Principal Investigator, Western University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.